In optimally treated patients with chronic heart failure, the use of a BNP-guided strategy has been reported to be associated with a lower risk of chronic heart failure-related death or hospitalization because of chronic heart failure than the use of a conventional strategy based on clinical expertise50. This evidence concerns the gene NPPB and congestive heart failure.